Paroxetine Tablet, Film Coated
Product Images NDC 68788-8829

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68788-8829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paroxetine Tab Usp 10mg (Image 01)

Label for Paroxetine Tab USP 10 mg film-coated tablets, generic for Paxil, manufactured by Zhejiang Huahai Pharmaceutical Technology Co. Ltd. The label includes storage instructions, a caution about federal law, dosage directions in English and Spanish, and various product identification codes. Preferred Pharmaceuticals Inc. is identified as the labeler.*

FDA Label Image

Picture1 (Image 05)

Chemical structure diagram of paroxetine hydrochloride hemihydrate, the active ingredient in Paroxetine 10 mg oral film-coated tablets by Preferred Pharmaceuticals Inc. The structure depicts its molecular bonds including a fluorophenyl group and a piperidine ring with hydrochloride attachment.*

FDA Label Image

Figure (Image 06)

A pharmacokinetic chart showing fold change and 90% confidence intervals of Cmax and AUC values for various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Figure2 (Image 07)

A pharmacokinetic graph showing fold change and 90% confidence intervals for Cmax and AUC parameters of various interacting drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam) relative to reference values. The x-axis represents change relative to reference from 0 to 2.*

FDA Label Image

Figure 3 (Image 08)

A scatter plot with error bars titled 'Fold change and 90% CI' displaying pharmacokinetic parameters (Cmax, Cmin, AUC) for paroxetine hydrochloride hemihydrate across different population subgroups. It compares changes relative to reference in groups with renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years with varying doses (20 mg, 30 mg, 40 mg once daily), and gender (males). The x-axis shows a logarithmic scale of change relative to reference from 0.5 to 50.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.